Earlier studies suggested that elevated O-GlcNAcylation levels resulting from increased expression of O-GlcNAc transferase (OGT) or inhibition of O-GlcNAcase (OGA) might contribute to insulin resistance through the hexosamine biosynthetic pathway (HBP) [62,63]. The gene discussed is OGT; the disease is Insulin resistance.